Latest Kaiser Health News Stories
The list of preventive services that insurers must cover without a co-pay could grow to include mammograms for younger women, testing that follows an irregular screening and birth control for men.
Research on patients with testicular cancer and others fighting a brain malignancy finds that people who are privately insured are more likely to be diagnosed earlier and survive longer.
Doctors are concerned that requiring referrals to genetic counselors can deter women from going forward with testing for genetic mutations that cause breast cancer.
Most screening tests for colon cancer are covered by insurance but if they come back positive, they may require a diagnostic colonoscopy and that may not be covered completely by insurance.
A review by the International Agency for Research on Cancer reaffirms earlier findings that excess body fat increases the risks for certain cancers.
The U.S. Preventive Services Task Force concluded that insufficient evidence exists regarding the benefits and harms of visual skin cancer exams.
California is the first state to begin building an up-to-date database to improve the diagnosis and treatment of cancer.
A study in JAMA finds palliative care counseling for families of chronically ill patients is not routinely needed by all and sometimes increases symptoms of post-traumatic stress.
Despite the usual view that physicians are slow to alter their routines based on new scientific evidence, researchers found that breast cancer surgeons quickly adopted advice to not remove lymph nodes after a landmark clinical trial in 2011.
Some say this trend is the future of biomedical research. But along with its potential, it also faces significant challenges.
Researchers concluded that physicians and other health professionals are less likely to know or accommodate the advanced-care preferences of patients with conditions such as renal disease or congestive heart failure, among others.
The U.S Preventive Services Task Force recently expanded the list of approved colorectal cancer screening tests. Here’s a primer on these various tests and how they might be covered now and in the future by health insurance.
A report by the Environmental Working Group measures how much Americans are exposed to a variety of chemicals that may be linked to cancer.
New research finds that patients infected with the virus that causes AIDS are less likely to get treatment for nine common cancers than are people who don’t have HIV.
The analysis by Avalere examines changes in how silver plans on the insurance marketplaces handle coverage for high-cost specialty drugs.
After Angelina Jolie disclosed her genetic predisposition for breast cancer, demand for genetic tests went up. Counselors help interpret those tests, and demand for their services has increased, too.
Researchers found that the facility fees hospitals and their clinics routinely add to the bill helps drive the price increases.
An MIT economist and Harvard oncologist propose offering loans to patients to cover the cost of expensive, curative drugs, financed by private sector investment in loan securities.
Terminal patients and doctors prepare themselves for California’s new assisted suicide law, which takes effect June 9.
The decision by Independence Blue Cross of Pennsylvania to pay for whole genome sequencing for some cancer patients adds to the debate about how to handle these expensive tests.